The treatment landscape for localized prostate cancer is rapidly evolving to achieve oncological disease control, simultaneously preserving gastrointestinal and genitourinary function. Focal therapy using cryoablation is an emerging treatment for prostate cancer. Short-term and intermediate-term clinical data on focal cryoablation therapy in prostate cancer have shown promising oncological and functional outcomes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Das, K., Benzil, D. L., Rovit, R. L., Murali, R. & Couldwell, W. T. Irving S. Cooper (1922-1985): a pioneer in functional neurosurgery. J. Neurosurg. 89, 865–873 (1998).
Gonder, M. J., Soanes, W. A. & Shulman, S. Cryosurgical treatment of the prostate. Invest. Urol. 3, 372–378 (1966).
Donnelly, B. J. et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer 116, 323–330 (2010).
Tan, W. P. et al. Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: a 20-year experience. Cancer https://doi.org/10.1002/cncr.34458 (2022).
Kenigsberg, A. P. et al. The use of magnetic resonance imaging to predict oncological control among candidates for focal ablation of prostate cancer. Urology 112, 121–125 (2018).
Wysock, J. S., Becher, E., Gogaj, R., Velazquez, N. & Lepor, H. Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone. Prostate Cancer Prostatic Dis. 24, 114–119 (2021).
Tan, W. P., Chang, A., Sze, C. & Polascik, T. J. Oncological and functional outcomes of patients undergoing individualized partial gland cryoablation of the prostate: a single-institution experience. J. Endourol. 35, 1290–1299 (2021).
Thakker, S., Wysock, J., Matulewicz, R., Gogaj, R. & Lepor, H. Early functional outcomes following partial gland cryo-ablation. Can. J. Urol. 29, 11128–11135 (2022).
Taha, T. et al. Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation? Curr. Urol. 15, 79–84 (2021).
Lebastchi, A. H. et al. Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus. Eur. Urol. 78, 371–378 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
Galil Medical: https://www.bostonscientific.com/en-US/products/cryoablation.html
Healthtronics: https://www.healthtronics.com/
Supplementary information
Rights and permissions
About this article
Cite this article
Tan, W.P., Wysock, J.S. & Lepor, H. Partial gland cryoablation for prostate cancer — where are we?. Nat Rev Urol 20, 127–128 (2023). https://doi.org/10.1038/s41585-022-00685-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00685-z